The CDC says New Mexico is one of more than 20 states in the “very high” level of influenza activity, the highest category.
Inhalon Biopharma's inhaled RSV antibody treatment will enter human trials marking a potential breakthrough in respiratory ...
RSV, respiratory syncytial virus, usually peaks in December and January while infecting the nose, throat and lungs, usually ...
ABC 7 Los Angeles on MSN8h
Flu, COVID and RSV surge in SoCal: Hospitals struggle as winter viruses hit hardJust over a month into the new year, influenza season is hitting hard in the Southland, and the flu isn't the only virus ...
US-based Inhalon Biopharma is set to launch a trial of its at-home nebulised treatment for respiratory syncytial virus (RSV) ...
It is a potentially fatal virus that can lead to hospitalisations and death in infants, but also in elderly and chronically ill adults. Two RSV vaccines were approved for use in Australia last ...
In the wake of multiple cases of human metapneumovirus (hMPV) in India, multiple questions about its causes and symptoms seem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback